C7ORF64 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.123400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.906800E-01
Normal-vs-Stage2
1.859980E-01
Normal-vs-Stage3
1.042610E-01
Normal-vs-Stage4
9.876400E-01
Stage1-vs-Stage2
1.331630E-01
Stage1-vs-Stage3
1.254010E-01
Stage1-vs-Stage4
8.607200E-01
Stage2-vs-Stage3
2.111600E-01
Stage2-vs-Stage4
1.204830E-01
Stage3-vs-Stage4
6.929700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.829840E-01
Normal-vs-AfricanAmerican
4.362400E-01
Normal-vs-Asian
6.196600E-01
Caucasian-vs-AfricanAmerican
7.863800E-01
Caucasian-vs-Asian
6.646800E-01
AfricanAmerican-vs-Asian
8.784600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.826160E-01
Normal-vs-Female
2.744200E-01
Male-vs-Female
5.095200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.759600E-01
Normal-vs-Age(41-60Yrs)
5.064800E-01
Normal-vs-Age(61-80Yrs)
1.369210E-01
Normal-vs-Age(81-100Yrs)
8.141900E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.716800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.446000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.671430E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.811600E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.920000E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.803200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.814400E-02
Normal-vs-Daily Drinker
3.971900E-02
Normal-vs-Weekly Drinker
4.964000E-02
Normal-vs-Occasional Drinker
5.044200E-01
Normal-vs-Social Drinker
2.820200E-01
Non Drinker-vs-Daily Drinker
7.025800E-01
Non Drinker-vs-Weekly Drinker
6.692600E-01
Non Drinker-vs-Occasional Drinker
2.548400E-02
Non Drinker-vs-Social Drinker
1.958760E-01
Daily Drinker-vs-Weekly Drinker
9.135200E-01
Daily Drinker-vs-Occasional Drinker
8.522800E-03
Daily Drinker-vs-Social Drinker
8.940500E-02
Weekly Drinker-vs-Occasional Drinker
1.558030E-02
Weekly Drinker-vs-Social Drinker
1.059240E-01
Occasional Drinker-vs-Social Drinker
4.098200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.895240E-01
Normal-vs-Grade 2
4.319500E-02
Normal-vs-Grade 3
4.304000E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.201400E-01
Grade 1-vs-Grade 3
9.086800E-01
Grade 1-vs-Grade 4
1.895240E-01
Grade 2-vs-Grade 3
9.730200E-01
Grade 2-vs-Grade 4
4.319500E-02
Grade 3-vs-Grade 4
4.304000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.568300E-02
Normal-vs-NonDiabetic
2.416600E-01
Diabetic-vs-NonDiabetic
1.029360E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.979950E-01
Normal-vs-NoPancreatitis
1.938820E-01
Pancreatitis-vs-NoPancreatitis
6.018600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.207800E-01
Normal-vs-N1
2.042000E-01
N0-vs-N1
9.891400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.871600E-01
Normal-vs-TP53-NonMutant
5.732400E-01
TP53-Mutant-vs-TP53-NonMutant
1.829840E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
